Want to see HK:8307 full AI Analyst Report?

Medicskin Holdings Ltd. (8307) Price & Analysis

Q: What was Medicskin Holdings Ltd.’s price range in the past 12 months?

Medicskin Holdings Ltd. lowest stock price was HK$0.02 and its highest was HK$0.24 in the past 12 months.

Q: What is Medicskin Holdings Ltd.’s market cap?

Medicskin Holdings Ltd.’s market cap is HK$48.80M.

Q: When is Medicskin Holdings Ltd.’s upcoming earnings report date?

Medicskin Holdings Ltd.’s upcoming earnings report date is Nov 16, 2026 which is in 117 days.

Q: How were Medicskin Holdings Ltd.’s earnings last quarter?

Medicskin Holdings Ltd. released its earnings results on Jun 22, 2026. The company reported HK$0.002 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.002.

Q: Is Medicskin Holdings Ltd. overvalued?

According to Wall Street analysts Medicskin Holdings Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Q: Does Medicskin Holdings Ltd. pay dividends?

Medicskin Holdings Ltd. pays a Notavailable dividend of HK$0.025 which represents an annual dividend yield of N/A. See more information on Medicskin Holdings Ltd. dividends here

Q: What is Medicskin Holdings Ltd.’s EPS estimate?

Medicskin Holdings Ltd.’s EPS estimate for its next earnings report is not yet available.

Q: How many shares outstanding does Medicskin Holdings Ltd. have?

Medicskin Holdings Ltd. has 396,736,000 shares outstanding.

Q: What happened to Medicskin Holdings Ltd.’s price movement after its last earnings report?

Medicskin Holdings Ltd. reported an EPS of HK$0.002 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 22.549%.

Q: Which hedge fund is a major shareholder of Medicskin Holdings Ltd.?

Currently, no hedge funds are holding shares in HK:8307

1 Followers

8307 Stock Chart & Stats

HK$0.17

HK$0.00(0.00%)

At close: Nov 11 4:00 PM EST

HK$0.17

HK$0.00(0.00%)

Day’s Range― - ―

52-Week RangeHK$0.02 - HK$0.24

Previous CloseN/A

Volume16.00K

Average Volume (3M)24.27K

Market Cap

HK$48.80M

Enterprise ValueHK$42.34M

Total Cash (Recent Filing)HK$29.46M

Total Debt (Recent Filing)HK$17.57M

Price to Earnings (P/E)1180.0

Beta0.25

Next Earnings

Nov 16, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)<0.01

Shares Outstanding396,736,000

10 Day Avg. Volume55,600

30 Day Avg. Volume24,266

Financial Highlights & Ratios

PEG Ratio-0.49

Price to Book (P/B)11.39

Price to Sales (P/S)1.24

P/FCF Ratio13.10

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Consistent Cash GenerationAnnual positive operating and free cash flow provide durable internal liquidity to fund operations, service debt and support modest reinvestment without immediate equity raises. Even with a FY2026 FCF decline, repeated cash generation materially reduces solvency risk and supports medium-term resilience.

Stable EBITDA MarginsMid‑teens EBITDA margins across multiple years indicate underlying operational economics that cover fixed costs and enable cash generation despite top-line swings. Durable operating margins improve ability to absorb revenue dips and sustain investment in service delivery over the next several quarters.

Return To ProfitabilityA return to net profitability in FY2026 after multi-year losses signals a potential inflection toward operational stabilization. Sustained earnings, coupled with positive cash flow, enhances capacity to deleverage, rebuild equity and fund strategic priorities over the medium term if trends persist.

Bears Say

Elevated LeverageVery high debt-to-equity and a small equity base materially increase balance-sheet risk and limit financial flexibility. Elevated leverage raises refinancing, interest and covenant risks, constraining the company's ability to invest, withstand revenue shocks or pursue growth without additional external funding.

Revenue Volatility And Recent DeclinePronounced revenue variability and a 16% decline in FY2026 undermine predictability for margins and cash flow. Persistent top-line instability weakens planning, increases dependency on cost controls, and reduces confidence in sustainable growth absent clearer demand or service mix recovery.

Sharp Gross Margin DeteriorationA marked fall in gross margin to ~37% indicates structural cost pressures or adverse mix changes that compress profitability. Lower gross margins reduce funds available for SG&A and reinvestment, making earnings and free cash flow more sensitive to demand fluctuations and cost volatility.

8307 FAQ

What was Medicskin Holdings Ltd.’s price range in the past 12 months?

Medicskin Holdings Ltd. lowest stock price was HK$0.02 and its highest was HK$0.24 in the past 12 months.

What is Medicskin Holdings Ltd.’s market cap?

Medicskin Holdings Ltd.’s market cap is HK$48.80M.

When is Medicskin Holdings Ltd.’s upcoming earnings report date?

Medicskin Holdings Ltd.’s upcoming earnings report date is Nov 16, 2026 which is in 117 days.

How were Medicskin Holdings Ltd.’s earnings last quarter?

Medicskin Holdings Ltd. released its earnings results on Jun 22, 2026. The company reported HK$0.002 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.002.

Is Medicskin Holdings Ltd. overvalued?

According to Wall Street analysts Medicskin Holdings Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Medicskin Holdings Ltd. pay dividends?

Medicskin Holdings Ltd. pays a Notavailable dividend of HK$0.025 which represents an annual dividend yield of N/A. See more information on Medicskin Holdings Ltd. dividends here

What is Medicskin Holdings Ltd.’s EPS estimate?

Medicskin Holdings Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Medicskin Holdings Ltd. have?

Medicskin Holdings Ltd. has 396,736,000 shares outstanding.

What happened to Medicskin Holdings Ltd.’s price movement after its last earnings report?

Medicskin Holdings Ltd. reported an EPS of HK$0.002 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 22.549%.

Which hedge fund is a major shareholder of Medicskin Holdings Ltd.?

Currently, no hedge funds are holding shares in HK:8307

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Medicskin Holdings Ltd.

Medicskin Holdings Limited, an investment holding company, provides medical skin care services in Hong Kong. The company operates Medicskin centers, which provides various medical skin care services for the treatment of skin diseases and problems, such as acne, pigmentation, rosacea, dermatitis, eczema, and warts, as well as improvement of appearance through inter alia, skin rejuvenation, facial sculpturing, and body contouring treatments; and treatment of acne scars and enlarged pores, removal of undesirable naevi, and hair removal. It provides medical consultancy services. In addition, the company engages in the sale of skincare products and medical skincare services. Further, it provides prevention healthcare services; body care and men care services, as well as offer mediskin vaccination. Medicskin Holdings Limited was founded in 2000 and is headquartered in Sheung Wan, Hong Kong. The company is a subsidiary of Topline Worldwide Limited.